Edo Vellenga

Prof. Dr. Edo Vellenga is a Full Professor at the Department of Hematology within the Faculty of Medical Sciences at the University of Groningen. His academic career spans over four decades, including roles as Assistant Professor (1987–1990) and Associate Professor (1990–2000). He currently leads the Cancer Research Center Groningen (CRCG) and holds editorial roles in hematology journals. His research focuses on hematologic malignancies, stem cell biology, and autophagy mechanisms in cancer.

Education: MD from University of Groningen (1978), followed by specialized training in Internal Medicine and Hematology at University Hospital Groningen. He completed fellowships at Harvard Medical School (1986–1987) and the Dr. Daniël den Hoed Cancer Center (1985–1986).

Research Interests: Leukemia treatment optimization, clonal hematopoiesis, myelodysplastic syndromes, and translational therapies targeting autophagy. His work integrates clinical trials (e.g., HOVON trials) with molecular mechanisms of disease progression.

Key Awards: Dutch Cancer Society Fellowship, Fulbright Scholarship, and membership in the Netherlands Academy of Arts and Sciences. He has authored over 500 publications, including seminal work on lenalidomide efficacy and autophagy guidelines.

Professional Contributions: Served as secretary of the Dutch Society of Hematology and HOVON, and currently chairs the HOVON’s vice role. His lab (CRCG) collaborates widely on oncology drug development and precision medicine strategies.